Related by context. All words. (Click for frequent words.) 81 Receives FDA Clearance 81 FDA Clears 81 FDA Approvals 80 Announces FDA Clearance 78 FDA Approval 78 k Clearance 76 Expanded Indication 76 Gets FDA Clearance 75 Patent Covering 75 Patient Enrollment 75 Files IND 74 FDA Accepts 74 Meets Primary Endpoint 74 IND Application 74 Receives Orphan Drug Designation 74 NDA Submission 74 Improves Survival 74 Fast Track Status 73 FDA Okays 73 Submits NDA 73 Drug Candidate 73 Initiate Clinical Trial 72 Milestone Payment 72 Clinical Trial Results 72 Demonstrates Significant 72 Granted Orphan Drug 72 Survival Benefit 72 Completes Patient Enrollment 72 Adjuvant Treatment 72 Advanced Melanoma 72 Clinical Trial Evaluating 72 Clinical Study Shows 71 Phase IIb Clinical Trial 71 Phase III Clinical Trial 71 Single Dose 71 #k Clearance 71 First Patient Treated 71 Phase IIb Trial 71 Phase 2b Clinical Trial 71 Pivotal Trial 71 Completes Enrollment 71 Prolongs Survival 71 FDA Approves 71 Generic Version 70 Phase III Trial 70 Pivotal Study 70 Initiates Clinical Trials 70 Mylan Receives Approval 70 Receives Approvable Letter 70 Psoriasis Drug 70 Supplemental Biologics License Application 70 Molecular Diagnostic Test 70 Patients Treated With 70 Prostate Cancer Vaccine 70 Contrast Agent 70 Pivotal Phase III 70 Obtains CE Mark 70 Proven Effective 70 Pivotal Clinical Trial 70 ORLive Presents 70 Improved Survival 70 Absorbable 70 Topical Treatment 70 Study Evaluating 70 Investigational Treatment 69 Initiates Clinical Trial 69 Demonstrates Positive 69 Less Invasive 69 Receives CE Marking 69 Taro Receives 69 AnaSpec Introduces 69 Significantly Reduced 69 Drug Eluting Coronary Stent 69 IND Filing 69 Receives Orphan Drug 69 Non Invasive 69 Preclinical Data 69 Intravenous Formulation 69 Lupus Drug 69 Shows Promising 69 Investigational Compound 69 Improves Outcomes 69 Rheumatoid Arthritis Drug 69 Significantly Reduces 69 Kidney Transplant Patients 69 Contrast Agents 69 Fungal Infections 69 Anti Inflammatory Drug 69 Present Preclinical Data 69 Medoxomil 69 Treatment Reduces 69 Generic Versions 69 Dry Powder Inhaler 69 Significantly Improves 69 Milestone Payment From 69 Patients Undergoing 69 Investigational Agent 69 GRAS Status 69 Initiates Enrollment 69 Receives CE 69 Seasonal Influenza Vaccine 69 Migraine Drug 69 Combination Treatment 69 Vascular Grafts 68 Microwave Ablation System 68 Phase 2b Trial 68 Blood Pressure Drug 68 Teva Provides Update 68 Combo Therapy 68 Low Dose 68 Testosterone Gel 68 Clinical Trial Data 68 NAVISTAR R 68 Long Term Efficacy 68 Cypher Sirolimus 68 Positive Opinion 68 Files Patent Application 68 Endovascular Treatment 68 FDA Approvable Letter 68 Gout Drug 68 Drug Shows Promise 68 Inhaled Insulin 68 Minimally Invasive Procedure 68 Left Atrial Appendage 68 Infusion Pumps 68 Interferon Gamma 68 Efficacy Trial 68 Drug Eluting 68 Dose Ranging Study 68 Advanced Colorectal Cancer 68 Cholesterol Lowering Drug 68 Well Tolerated 68 Surgical Mesh 68 Non Invasive Treatment 68 Study Demonstrates 68 Adjuvant Chemotherapy 68 Breast Biopsy 68 Initiates Clinical 68 Drug Eluting Stent 68 Phase IIa Clinical Trial 68 Generic Version Of 68 Develop Novel 68 Regenerative Cells 68 Shows Promise Against 68 Tumor Targeting 68 Breast Cancer Recurrence 68 Transdermal Patch 68 Anti Tumor Activity 68 Stent Coating 68 REPRONEX R menotropins 68 Overactive Bladder 68 Complicated Skin 68 Reduces Pain 68 Phase 2a Trial 68 Wound Dressing 68 Hip Implants 68 Osteoporosis Drug 68 Adjuvant Therapy 68 Study Showed 68 Diagnostic Tests 68 Metastatic Colorectal Cancer 68 Neoadjuvant Chemotherapy 67 Anti Tumor 67 Rheumatoid Arthritis Patients 67 Receives Fast Track 67 Patients Treated 67 Presents Preclinical Data 67 Interferon Alpha 67 Minimally Invasive Treatment 67 Drug Fails 67 Improve Survival 67 Demonstrates Potential 67 Pharmacokinetic Study 67 Detection Device 67 Oral Mucositis 67 Obtains FDA 67 Coronary Stents 67 First Patient Dosed 67 Patent Issued 67 Vascular Graft 67 Nicotine Vaccine 67 Reduces Risk 67 BioElectronics Announces 67 Osteoporosis Treatment 67 Announces Tentative Approval 67 Receives SFDA Approval 67 JAK Inhibitor 67 Asthma Treatment 67 Data Suggest 67 Inhaled Nitric Oxide 67 Regulatory Clearance 67 Prophylactic Treatment 67 Lung Cancer Drug 67 Clinical Outcome 67 Spinal Fusion 67 Significantly Improved 67 Embolic Protection 67 injectable bulking agent 67 PDUFA Date 67 Receives Patent 67 Epilepsy Drug 67 Fibrin Sealant 67 PROMUS TM 67 Patient Treated 67 Drug Coated Stent 67 Wound Closure 67 Combination REOLYSIN R 67 Enrolls First 67 HCV Protease Inhibitor 67 Randomized Clinical Trial 67 Vaccine Candidate 67 SFDA Approval 67 Implantable Device 67 PRN FDA Approves 67 Stem Cell Treatment 67 Prospective Randomized 67 II Clinical Trial 67 Files Investigational 67 Receives Milestone Payment 67 Anticancer Activity 67 Novel Antibiotic 67 Previously Treated 67 Androgen Deprivation Therapy 67 Combination Therapy 67 Unfractionated Heparin 66 Uracyst R Test 66 Glaucoma Treatment 66 Metastatic Melanoma 66 Presents Positive 66 Device Maker 66 Genetic Tests 66 Systemic Delivery 66 Treatment Regimen 66 Receptor Agonist 66 Surgical Procedures 66 Orphan Drug Status 66 Treating Chronic 66 Pediatric Patients 66 Begins Shipment 66 Zorbtive TM 66 Statistically Significant 66 Immunoassay System 66 Trial Evaluating 66 Arthritis Drug 66 Advanced Renal Cell 66 Achieves Primary Endpoint 66 Chronic Sinusitis 66 Treated Patients 66 Is Well Tolerated 66 Therapeutic Vaccine 66 liver resection surgeries 66 Infected Patients 66 Thrombectomy System 66 Test Detects 66 Extended Release 66 Hormone Receptor Positive 66 ENLIGHT 66 Microplate Readers 66 Treatment Resistant 66 Myeloma Patients 66 Prognostic Value 66 Pulmonary Artery 66 Therapy Reduces 66 Pooled Analysis 66 CE Marked 66 Advanced Prostate Cancer 66 Brain Metastases 66 Chemoradiation 66 Phase 2a Clinical Trial 66 Prostate Cancer Patients 66 Clinical Efficacy 66 Appears Safe 66 FDA APPROVES 66 HER2 Positive Breast Cancer 66 Tezampanel 66 Bioresorbable 66 First Patient Enrolled 66 Issued Patent 66 NASDAQ Deficiency Notice 66 Testosterone Patch 66 Patients Enrolled 66 Elderly Patients 66 Novel Compound 66 DOR BioPharma Announces 66 Patents Covering 66 Intravascular 66 Oral Fluid 66 Successfully Completes Phase 66 Myelodysplastic Syndromes 66 Demonstrates Efficacy 66 Hip Prosthesis 66 Antitumor Activity 66 Spinal Implant 66 Surgical Sealant 66 Milestone Payments 66 Beta Blocker 66 Begin Clinical Trials 66 Heart Failure Patients 66 FDA Panel Recommends 66 vapreotide acetate 66 Peripherally Inserted Central 66 TM Embolic Protection 66 Announce License Agreement 66 Generic Protonix 66 PATHFINDER ® TRACER 66 Disease Modifying 66 Receives Positive Opinion 66 Proves Effective 66 Significant Reduction 66 Carotid Stent System 66 Knee Implant 66 Novel Oral 66 Phase 1b Clinical Trial 66 TM Drug Eluting 66 Initiates Phase II 65 Dual Wavelength 65 Recombinant Human 65 Vitrasert R 65 Dural Regeneration Matrix 65 Tissue Engineered 65 Commence Phase 65 Submits Supplemental 65 Vaginal Gel 65 Hypertensive Patients 65 Fracture Risk 65 Orphan Status 65 Drug Prevents 65 Drug Resistant 65 Articular Cartilage 65 Obese Patients 65 Acute Ischemic Stroke 65 Effectively Treats 65 Disease Progression 65 Expedited Review 65 Aortic Valve Replacement 65 Oral Cladribine 65 Significant Improvement 65 Estrogen Therapy 65 Showed Significant 65 Previously Untreated 65 Successfully Treats 65 Novel Inhibitor 65 Oral Interferon 65 Transdermal Drug 65 Submits Application 65 Chemotherapy Regimen 65 Anemia Drug 65 Monoclonal Antibody 65 Contrast Enhanced 65 Bioartificial Liver 65 Lung Cancer Trial 65 Smooth Muscle 65 Pulse Oximetry 65 Diabetic Patients 65 Mouse Model 65 Shows Promise 65 Adjunctive Therapy 65 Blood Glucose Meters 65 Immunomedics Announces 65 Study Evaluates 65 Heart Stents 65 Pre Cancerous 65 Significant Improvements 65 Recurrent Breast Cancer 65 Blood Clotting 65 Awarded Patent 65 Blood Glucose Meter 65 Topical Cream 65 Patients Receiving 65 Inhaled Corticosteroids 65 Confirmatory Phase 65 Gliadel R 65 Osteoporosis Drugs 65 Anticancer Drug 65 Therapy Improves 65 Metabolic Disorder 65 Renal Cancer 65 Prostate Cancer Treatment 65 Nasdaq Deficiency Notice 65 Package Insert 65 Elevated Levels 65 Schizophrenia Drug 65 Introduces Revolutionary 65 Sagent Pharmaceuticals Announces 65 Improves Quality 65 Antimicrobial Coating 65 Commences Phase 65 TM Everolimus Eluting 65 Successfully Treated 65 Multiple Myeloma Patients 65 REVELATION ® 65 Pivotal Phase 65 Topical Gel 65 Antiviral Drugs 65 Severe Sepsis 65 Nail Fungus 65 Cholesterol Drug 65 Protein Expression 65 Phase III Trials 65 Bare Metal Stent 65 PERLANE 65 External Defibrillators 65 Plaque Psoriasis 65 ™ Everolimus Eluting 65 Knee Osteoarthritis 65 Submits Response 65 Silicone Breast Implants 65 Flagship Product 65 Tyrosine Kinase Inhibitor 65 Thoracic Endoprosthesis 65 FDA Approves Expanded 65 Balloon Catheter 65 FDA Warns 65 Gene Variant 65 Slow Progression 65 Axxent R 65 Post Operative 65 Anti Nausea 65 Schizophrenia Treatment 65 Dose Escalation 65 Approvable 65 Colorectal Cancer Patients 65 Autologous Stem Cell Transplantation 65 Treatment Naïve 65 Stakeholder Opinions 65 Announces Initiation 65 Soft Tissue Sarcoma 65 Blood Thinner 65 Mycophenolate Mofetil 65 Anticoagulant 65 Sign Licensing Agreement 65 Circulating Tumor Cells 64 Lymph Node 64 Patients Suffering 64 Cholesterol Lowering 64 Orphan Designation 64 Hormone Refractory Prostate Cancer 64 Wound Dressings 64 Recall Issued 64 Vaccine Adjuvant 64 Altera Ships 64 Immunosuppressant 64 Resubmission 64 Predict Risk 64 Increased Mortality 64 Breast Cancer Treatment 64 Weight Loss Drug 64 Sirolimus Eluting Stent 64 Cancer Treatments 64 candidates Azedra 64 Smallpox Vaccine 64 Aloprim TM allopurinol sodium 64 Sumatriptan Succinate 64 Glucose Control 64 Diabetic Neuropathy 64 Bone Graft 64 Infectious Disease Testing 64 Thrombectomy 64 Demonstrates Potent 64 Anticancer Agent 64 Peginterferon 64 Computer Aided Detection 64 Maleate 64 Kidney Function 64 Eluting Stent 64 Confirms Efficacy 64 Intravitreal 64 Renal Cell Carcinoma 64 Hernia Repair 64 Guidelines Issued 64 ATS Simulus R 64 Kinase Inhibitor 64 Respiratory Virus 64 Insulin Pen 64 Commercialize Novel 64 THERMOCOOL R 64 Shows Efficacy 64 BIOLASE Announces 64 Immune Responses 64 Benign Prostatic Hyperplasia 64 Therapeutic Competitors Companies 64 Diagnostic Tools 64 MR Angiography 64 Hepatitis C Genotype 64 Haemophilus b Conjugate 64 Commercially Available 64 Glucose Monitoring 64 Resistant Hypertension 64 Demonstrates Statistically Significant 64 VISICOL R 64 Chronic Hepatitis C 64 Gene Mutation 64 REMINDER ORLive Presents 64 ST Elevation Myocardial 64 FDA Orphan Drug 64 Efficacy Results 64 Clinically Proven 64 HER2 Positive 64 Microspheres 64 Protease Inhibitor 64 Metformin HCl 64 Invasive Fungal Infections 64 Glatiramer Acetate 64 Bosutinib 64 Blocked Arteries 64 Artery Disease 64 Tablet Formulation 64 Oral Calcitonin 64 Phase 2b Study 64 Oral Mist 64 WorldHeart Announces 64 Patent Broadly Covering 64 Embolization 64 Lowers Risk 64 Million Milestone Payment 64 Shingles Vaccine 64 Erectile Dysfunction Drug 64 RNAi Therapeutic 64 Blood Pressure Reduction 64 Balloon Angioplasty 64 Rapid Detection 64 Replacement Therapy 64 Eliminates Need 64 Novel Compounds 64 Nasdaq SMTS develops manufactures 64 Nasdaq Listing Requirements 64 Controlled Study 64 Corneal Transplant 64 Femtosecond Laser 64 NICE Recommends 64 Embolic 64 Agilent Technologies Introduces 64 Percutaneous Tibial Nerve Stimulation 64 Spectrum Pharmaceuticals Announces 64 Electrical Stimulation 64 Lupus Nephritis 64 Combination Clinical Trial 64 Therapeutic Efficacy 64 Intravenous Human 64 Oral Spray 64 Intraocular Lens 64 Postmenopausal Osteoporosis 64 Bepreve TM 64 Lung Cancer Survival 64 IIa Clinical Trial 64 CT Angiography 64 Atopic Dermatitis 64 Zicam Cold Remedy RapidMelts 64 Adenoma 64 Node Positive 64 Bare Metal Stents 64 Cardiogenic Shock 64 Technological Advances 64 Phase III Clinical Trials 64 Voluntary Withdrawal 64 Microcatheter 64 Cervical Imaging 64 Investigational Oral 64 Bone Metastases 64 Pain Relievers 64 Commercialize 64 Initiates Dosing 64 Launches Generic Version 64 Platinum Chromium 64 Imaging Technique 64 Humanized Anti 64 Breast Tumors 64 Demonstrates Improved 64 Drug Combo 64 Preclinical Study 64 Efficacious 64 Miraculins Announces 64 Fewer Side Effects 64 Localized Prostate Cancer 64 Diabetic Foot Ulcer 64 Shoulder Prosthesis 64 AVANIR Pharmaceuticals Announces 64 Dynamic Stabilization 64 Immunomodulatory 64 Compression Therapy 64 Could Predict 64 Long Term Survival 64 Ultrasound Imaging 63 Treatment Naïve Patients 63 Anti Inflammatory 63 sodium benzoate prescription 63 Pre Owned Vehicle 63 Bazedoxifene 63 Eluting Coronary Stent System 63 Cosmetic Procedure 63 Robotic Assisted 63 Could Detect 63 TRANSDUR ™ 63 Wrinkle Treatment 63 FDA Warns Against 63 Conditional Approval 63 Biomarker Study 63 Virus Infection 63 INDUSTRY ASSESSMENTS 63 Covered Stent 63 Aneurysm Repair 63 Catheter Ablation 63 Pulmonary Valve 63 Indevus Pharma 63 Reduced Risk 63 Drug Eluting Stent System 63 Indomethacin 63 TRANSDUR ® 63 Microchip Technology Introduces 63 Skin Care Line 63 Anemia Drugs 63 Hip Fractures 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 Synthetic Peptide 63 Exclusive License 63 Optical Biopsy System 63 Perflubutane Polymer Microspheres 63 Vertebral Compression Fractures 63 NexMed Receives 63 Deep Venous Thrombosis 63 Carboplatin Paclitaxel 63 Spinal Cord Stimulator 63 Left Ventricular 63 Isavuconazole 63 Hematological Cancers 63 Molecular Mechanism 63 Auto Injector 63 Premarket Approval 63 Chemotherapy Induced 63 Commercializes 63 VIVUS Announces 63 Immunogenicity 63 Osteoarthritis Patients 63 Molecular Diagnostic 63 Nasdaq Delisting Notice 63 Infusion Pump 63 Diet Pill 63 lexidronam injection 63 Achieves Milestone 63 Antibiotic Treatment 63 Ebola Vaccine 63 Small Molecule 63 Release Capsules 63 Unigene nasal calcitonin 63 Epilepsy Drugs 63 Intravesical 63 Monotherapy 63 Fixed Dose Combination 63 Tentative Approval 63 Bone Grafts 63 Ablation System 63 Cellulite Reduction 63 Demonstrates Sustained 63 Oral Fingolimod 63 Veeco Introduces 63 Prove Effective 63 Study Casts Doubt 63 Sirolimus eluting Coronary Stent 63 Bloodstream Infections 63 ANDA Filing 63 Nasdaq Notice Regarding 63 Pneumococcal Vaccine 63 INTELLITEMP ® 63 Cardiovascular Prosthetic Devices 63 Hepatitis B Vaccine 63 STELARA TM 63 Aztreonam Lysine 63 SBIR Grant 63 Autologous Thrombin Processing 63 Initiate Phase 63 Obtains Exclusive License 63 Surgical Ablation 63 Image Guided 63 Melphalan 63 Potent Anti 63 Transdermal System 63 Significantly Increases 63 Oral Contraceptive 63 Versus Placebo 63 Abdominal Stent Graft 63 Acne Medication 63 Biocompatibility 63 Receives Clearance 63 Lung Cancer Patients 63 Bacteremia 63 Spinal Fluid 63 Sevelamer 63 Tecnis R 63 QL Care Analyzer 63 Initiate Phase III 63 MicroPulse 63 Strengthens Balance Sheet 63 Stent Placement 63 Fluticasone 63 Levels Linked 63 Patent Infringement Suit 63 Heartburn Drugs 63 Misonix Announces 63 Gene Variation 63 Highly Accurate 63 Glucose Monitor 63 PROMUS ® 63 Licenses Novel 63 Immunotherapeutic 63 RNAi Therapeutics 63 Biliary System 63 Receives Notification 63 Fluconazole 63 Announce Collaboration Agreement 63 Enlarged Prostate 63 Dupuytren Contracture 63 ™ Paclitaxel Eluting 63 Epidermal Growth Factor Receptor 63 Vitro Diagnostic 63 Patents Issued 63 Reports Preclinical Data 63 Metastatic Prostate Cancer 63 Anticancer Drugs 63 Shows Statistically Significant 63 Respiratory Distress 63 Postmenopausal Women 63 Dilatation 63 Antiepileptic 63 NTIOL 63 Newly Identified 63 Injectable Gel 63 Inhalation Aerosol 63 Study Shows Benefits 63 Receives Marketing Authorization 63 refractory recurrent 63 Randomized Trials 63 Carotid Stent 63 Kidney Transplant Recipients 63 Stronger Warnings 63 Plus Ribavirin 63 CHMP Opinion 63 Cardiovascular Monitoring 63 Drug Coated Stents 63 RNA Amplification 63 Radiofrequency Ablation 63 Crit Rev 63 endoluminal stent graft 63 Radical Prostatectomy 63 Myocardial Perfusion Imaging 63 Demonstrates Ability 63 ZEVALIN ® 63 Sodium Injection 63 Subgroup Analysis 63 Holds Promise 63 Allografts 63 Therapeutic Antibody 63 Palonosetron 63 Aloxi ® 63 Diabetic Nephropathy 63 Atypical Antipsychotics 63 Oral Insulin 63 Generic Equivalent 63 Mg Uk 63 Initiates Phase III 63 KL4 Surfactant 63 topically applied SEPA 63 Genes Linked 63 Hypercholesterolemia 63 Tumor Growth 63 Slows Progression 63 Lyophilized 63 Breast Cancer Cells 63 Anti Clotting Drug 63 Fast Track Designation 63 Avago Technologies Announces 63 Flamel Technologies Announces 63 Potent Antiviral Activity 63 Collaborators Present 63 Drug Eluting Stents 63 TAXUS Element Paclitaxel Eluting 63 Tumor Cells 63 Randomized Clinical Trials 63 Hemostatic 63 Unresectable 63 REPRONEX ® menotropins 62 Enteral Feed Devices 62 Aspheric 62 Posaconazole 62 Investigational Drug 62 Marketing Authorisation Application 62 Oxaliplatin Injection 62 Results Confirm 62 AMPLATZER R 62 Aortic Aneurysm 62 Measurement Instruments 62 Allograft 62 Blood Glucose Testing 62 Surgical Technique 62 Patient Enrolment 62 FUSILEV ® 62 Accelerated Approval 62 Pulmonary Arterial Hypertension 62 Submits Biologics License Application 62 Announce Merger Agreement 62 SinoFresh TM 62 Orally Active 62 Weight Loss Pill 62 Cellegesic 62 Breast Implant 62 Topical Suspension 62 Statin Therapy 62 Spinal Elements 62 Cervical Cancer Vaccine 62 KEMET Announces 62 Newly Diagnosed Multiple Myeloma 62 Renal Function 62 MSON 62 Earns Milestone Payment 62 Pulsatile 62 COLAZAL ® 62 Personalized Immunotherapy 62 Anti CD# Antibody 62 ISSI Announces 62 Assay Kit 62 Therapy Evaluation 62 FORE SIGHT Absolute Cerebral 62 Oximeter 62 Regains NASDAQ 62 Transdermal Delivery 62 Resurfacing System 62 Cell Transplants 62 Cardiovascular Disease Risk 62 Attenuates 62 NYSE Amex Listing 62 Seasonal Allergic Rhinitis 62 Sustained Release 62 ALVESCO ® 62 Artificial Disc 62 Self Expanding Stent 62 CyberKnife Radiosurgery 62 Aortic Valve 62 Cardiac Marker 62 Study Shows Significant 62 Cold Sores 62 Coronary Arteries 62 topical gel formulation 62 Virus Linked 62 Adhesion Barrier 62 Artificial Skin 62 Migraine Treatment 62 Balloon Catheters 62 Antibiotic Resistant 62 Gene Linked 62 Central Venous Catheters 62 Liberte TM 62 Endeavor Drug Eluting 62 Hsp# Inhibitor 62 Taclonex R 62 Diabetic Ulcers 62 Acute Heart Failure 62 Progenitor Cells 62 Being Studied 62 Anti infective 62 Proves Successful 62 Gene Expression Analysis 62 Device Helps 62 acetonide FA 62 CLIA Waiver 62 Genetic Mutation 62 Male Contraceptive 62 Endometrial Cancer 62 Announces License Agreement 62 FDA Approves Drug 62 Acne Scars 62 Cardiac Resynchronization Therapy 62 Intracranial Aneurysms 62 Premarket Approval Application 62 Pivotal Trials 62 Malignant Melanoma 62 See CLINICAL PHARMACOLOGY 62 Treat Heart Failure 62 Awarded Qualifying Therapeutic 62 #mg Tablets [002] 62 Liposomal 62 Skin Lesions 62 Initiates Phase 62 Sestamibi 62 Relapsing Multiple Sclerosis 62 Lung Cancer Detection 62 Liver Failure 62 Therapeutic Potential 62 Vascular Closure Device 62 Phase III Pivotal Trial 62 Sublingual 62 Ultrasensitive 62 Novel Method 62 Critically Ill Patients 62 Enhanced Version 62 Dosage Forms 62 Lung Cancer Treatment 62 Parathyroid Hormone 62 Treatment Shows Promise 62 Generic Lovenox 62 Endurant 62 brand ciclesonide HFA 62 Genes Involved 62 Heart Transplant Recipients 62 Tolerability 62 Fast Track designations 62 XIENCE PRIME TM 62 Soft Tissue 62 Guidelines Recommend 62 Chronic Hepatitis B 62 Xolegel 62 Cholesterol Drugs 62 Advanced Microspheres 62 Blood Glucose Monitoring 62 PROSTASCINT R 62 Experimental Vaccine 62 Skin Resurfacing 62 HCl Injection 62 PresbyLens ® 62 Clinical Study 62 Long Lasting 62 Demonstrates Superior 62 Atherectomy 62 Achieves Unprecedented 62 Novel Protein 62 Quantitation 62 Sustained Reduction 62 AneuRx AAAdvantage 62 Skeletal Muscle 62 Prolongs Life 62 Dose Finding 62 Anti Angiogenic 62 Nucleoside 62 Dual Antiplatelet Therapy 62 DNA Methylation 62 Topline Results 62 COVIDIEN 62 Acute Attacks 62 Sunesis Pharma 62 Prodrug 62 PROTONIX 62 Ultrasound Guided 62 Provides Update Regarding 62 Magnetic Stimulation 62 Reduces Mortality 62 Antitumor 62 Coronary Stent 62 Silicon Wafer 62 Successfully Tested 62 Improve Outcomes 62 Desvenlafaxine Succinate 62 Sapacitabine 62 Everolimus Eluting Coronary Stent 62 Regulatory Approval 62 Nanoemulsion 62 ® chorionic gonadotropin 62 Clinical Evaluation 62 Anika Therapeutics 62 Clinically Tested 62 Macroplastique ® 62 Levoleucovorin 62 Brimonidine 62 Receives Tentative Approval 62 Injectable Drug 62 Metastatic Renal Cell Carcinoma 62 Insulin Delivery 62 Prognostic Significance 62 Measurement Devices 62 Verisyse TM intraocular lenses 62 Cardiac Function 62 Dramatically Increases 62 Immune Cell 62 Pain Medications 62 IV Busulfex 62 Hand Sanitizers 62 Ultra Sensitive 62 Electronic Brachytherapy System 62 Treatment Naive Patients 62 Cardiac Troponin 62 Lowers Blood Pressure 62 Mitral Valve Repair 62 Possible Contamination 62 Gene Variants 62 TriCo Bancshares Announces 62 Stent Restenosis 62 Radiotherapy Treatment 62 Sustained Efficacy 62 Stent Implantation 62 Companion Diagnostic 62 Helps Predict 62 Radioimmunotherapy 62 Aurora Kinase 62 Safety Syringes 62 Curon Control 62 Full Prescribing Information 62 OSMOPREP TM 62 Pharmacokinetics PK 62 Antiviral Activity 62 Inflammatory Disease 62 Cocaine Addiction 62 Hepatitis C Treatment